Mobile Transmission of Prehospital Vital Signs to the Emergency Department

April 23, 2014 updated by: Nikolaj Raaber, University of Aarhus

Telemedical Solutions in Medical Emergencies, Advantages and Disadvantages for Patients, Healthcare Professionals, and the Healthcare System: Study 1: "Mobile Transmission of Prehospital Vital Signs to the Emergency Department - Effect on Patient Outcomes, Treatment and Diagnosis"

The purpose of this study is to examine if real time transmission of vital signs, ECG and chat communication between the prehospital ambulances and the emergency department has an effect on patient mortality, ICU admission, hospitalization time, time to doctor, time to treatment and time to diagnostics

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Anticipated)

250

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Denmark
      • Aarhus N, Denmark, 8200
        • Prehospital Emergency Medical Services, Aarhus, Central Denmark Region
      • Horsens, Denmark, 8700
        • Horsens Regional Hospital, Central Region Denmark
      • Horsens, Denmark, 8700
        • Responce A/S

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

15 years and older (Child, Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • All patients transported with ambulance to the emergency department

Exclusion Criteria:

  • None

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: Non-Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Transmission of vital signs, ecg, chat
Data from patients transported in ambulances with equipment which enables real time transmission of vital signs, ecg and chat from ambulances to the emergency department.
Device: Real time transmission of patient related data. Device used: MobiMed 3.1, manufactured by Ortivus AB Sweden
Other Names:
  • Vital signs, ECG and Chat-messaging delivered real time from prehospital ambulances to the receiving emergency dept.
No Intervention: No transmission of data
Patient transported with conventional ambulances without the possibility to transmit real time patient related data.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Time to physician
Time Frame: Time from arrival to first patient-physician contact, assessed up to 36 months
Time from the patient arrival registered in the patients' logistics system (Cetrea) to registered first patient/physician contact registered in the same patients logistics system.
Time from arrival to first patient-physician contact, assessed up to 36 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
All cause mortality
Time Frame: 30 days, assessed up to 36 months
30 days, assessed up to 36 months
Time to treatment
Time Frame: Time from arrival to administration of first iv. antibiotics, assessed up to 36 months
Time from the patient arrival registered in the patients' logistics system (Cetrea) to first administered iv antibiotics registered in the patient's hospital record
Time from arrival to administration of first iv. antibiotics, assessed up to 36 months
Time to x-ray
Time Frame: Time form arrival at the emergency department to completion of x-ray requisition form, assessed up to 36 months
Time from the patient arrival registered in the patients' logistics system (Cetrea) to completion of x-ray requisition form registered in the radiologic logistics system (Kodak RIS, 2010 edition)
Time form arrival at the emergency department to completion of x-ray requisition form, assessed up to 36 months
Time to ICU
Time Frame: Time from arrival to admission to the ICU, assessed up to 36 months
Time from the patient arrival registered in the patients' logistics system (Cetrea) to time of admission to the ICU registered in the patient's hospital record. .
Time from arrival to admission to the ICU, assessed up to 36 months
Number of ICU admissions
Time Frame: During present hospitalization, assessed up to 36 months
During present hospitalization, assessed up to 36 months

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Emergency department staff evaluation of usability of equipment
Time Frame: At the time of using the equipment, assessed up to 36 months
The staff at the emergency department fill out a survey after the use of the equipment which provides ecg, vital signs, chat.
At the time of using the equipment, assessed up to 36 months
Ambulance staff evaluation of usability of equipment
Time Frame: At the time of using the equipment, assessed up to 36 months
The ambulance staff fill out a survey after the use of the equipment which provides ecg, vital signs, chat.
At the time of using the equipment, assessed up to 36 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

University of Aarhus

Collaborators

Aarhus University Hospital
Central Denmark Region

Investigators

  • Study Director: Erika F. Christensen, MD, Medical director, Central Denmark Region

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

June 1, 2013

Primary Completion (Actual)

March 1, 2014

Study Completion (Actual)

March 1, 2014

Study Registration Dates

First Submitted

February 20, 2014

First Submitted That Met QC Criteria

March 14, 2014

First Posted (Estimate)

March 18, 2014

Study Record Updates

Last Update Posted (Estimate)

April 24, 2014

Last Update Submitted That Met QC Criteria

April 23, 2014

Last Verified

April 1, 2014

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • NRAA

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Telemedicine

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Costa Rica

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe